Cathepsins S, L, and K and their pathophysiological relevance in obesity

Clinical Reviews in Bone and Mineral Metabolism

Volumn 9, Issue 2, 2011, Pages 133-137

  Lafarge, Jean Charles ^a,b,c   Clément, Karine ^a,b,c,d   Guerre Millo, Michèle ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Center of Research on Human Nutrition Ile de France   (France)

Author keywords

Adipose tissue; Cathepsins; Glucose tolerance; Metabolic diseases; Obesity

Indexed keywords

CATHEPSIN K; CATHEPSIN K INHIBITOR; CATHEPSIN L; CATHEPSIN S; CATHEPSIN S INHIBITOR; ODANACATIB;

ADIPOSE TISSUE; ARTICLE; BODY MASS; CELL DIFFERENTIATION; GLUCOSE HOMEOSTASIS; HUMAN; NONHUMAN; OBESITY; WEIGHT GAIN;

EID: 79960034254     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-011-9096-4     Document Type: Article

References (29)

1. M Guerre-Millo 2004 Adipose tissue and adipokines: for better or worse Diabetes Metab 30 13 19 15029093 10.1016/S1262-3636(07)70084-8 1:CAS:528:DC%2BD2cXjvFygtbs%3D
2. P Trayhurn IS Wood 2005 Signalling role of adipose tissue: adipokines and inflammation in obesity Biochem Soc Trans 33 1078 1081 16246049 10.1042/BST20051078 1:CAS:528:DC%2BD2MXhtFCqs7nM (Pubitemid 41659117)
3. M Ferron E Hinoi G Karsenty P Ducy 2008 Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice Proc Natl Acad Sci USA 105 5266 5270 18362359 10.1073/pnas.0711119105 1:CAS:528:DC%2BD1cXksVOns7Y%3D (Pubitemid 351738545)
4. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone. 2011 [Epub ahead of print].
5. I Kanazawa T Yamaguchi Y Tada M Yamauchi S Yano T Sugimoto 2011 Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes Bone 48 720 725 21185419 10.1016/j.bone.2010.12.020 1:CAS:528:DC%2BC3MXjs12jtb0%3D
6. I Kanazawa T Yamaguchi M Yamauchi M Yamamoto S Kurioka S Yano T Sugimoto 2011 Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus Osteoporos Int 22 187 194 20165834 10.1007/s00198-010-1184-7 1:CAS:528:DC%2BC3MXjtVaqtg%3D%3D
7. D Kajimura E Hinoi M Ferron A Kode KJ Riley B Zhou XE Guo G Karsenty 2011 Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual J Exp Med 208 841 851 21444660 10.1084/jem.20102608 1:CAS:528:DC%2BC3MXkvFCrs7k%3D
8. Y Mitsui M Gotoh N Fukushima I Shirachi S Otabe X Yuan T Hashinaga N Wada A Mitsui T Yoshida S Yoshida K Yamada K Nagata 2011 Hyperadiponectinemia enhances bone formation in mice BMC Musculoskelet Disord 12 18 21241476 10.1186/1471-2474-12-18 1:CAS:528:DC%2BC3MXht1Oiu70%3D
9. M Ferron J Wei T Yoshizawa A Del Fattore RA DePinho A Teti P Ducy G Karsenty 2010 Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism Cell 142 296 308 20655470 10.1016/j.cell.2010.06.003 1:CAS:528:DC%2BC3cXpsVahsr4%3D
10. TD Rachner S Khosla LC Hofbauer 2011 Osteoporosis: now and the future Lancet 377 1276 1287 21450337 10.1016/S0140-6736(10)62349-5 1:CAS:528: DC%2BC3MXksFWit7c%3D
11. C Chiellini M Costa SE Novelli EZ Amri L Benzi A Bertacca P Cohen S Del Prato JM Friedman M Maffei 2003 Identification of cathepsin K as a novel marker of adiposity in white adipose tissue J Cell Physiol 195 309 321 12652657 10.1002/jcp.10253 1:CAS:528:DC%2BD3sXislOmuro%3D (Pubitemid 36384304)
12. S Taleb D Lacasa JP Bastard C Poitou R Cancello V Pelloux N Viguerie A Benis JD Zucker JL Bouillot C Coussieu A Basdevant D Langin K Clement 2005 Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis FASEB J 19 1540 1542 15985526 1:CAS:528:DC%2BD2MXpvF2gtrw%3D (Pubitemid 41279024)
13. M Yang Y Zhang J Pan J Sun J Liu P Libby GK Sukhova A Doria N Katunuma OD Peroni M Guerre-Millo BB Kahn K Clement GP Shi 2007 Cathepsin L activity controls adipogenesis and glucose tolerance Nat.Cell Biol 9 970 977 17643114 1:CAS:528:DC%2BD2sXosVSltbw%3D (Pubitemid 47190452)
14. N Naour C Rouault S Fellahi ME Lavoie C Poitou M Keophiphath D Eberle S Shoelson S Rizkalla JP Bastard R Rabasa-Lhoret K Clement M Guerre-Millo 2010 Cathepsins in human obesity: changes in energy balance predominantly affect cathepsin s in adipose tissue and in circulation J Clin Endocrinol Metab 95 1861 1868 20164293 10.1210/jc.2009-1894 1:CAS:528:DC%2BC3cXltFSnsLs%3D
15. S Taleb R Cancello C Poitou C Rouault P Sellam P Levy JL Bouillot C Coussieu A Basdevant M Guerre-Millo D Lacasa K Clement 2006 Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women J Clin.Endocrinol Metab. 91 1042 1047 16394095 10.1210/jc.2005-1601 1:CAS:528:DC%2BD28Xis1Cmur8%3D (Pubitemid 43357778)
16. GP Shi JA Villadangos G Dranoff C Small L Gu KJ Haley R Riese HL Ploegh HA Chapman 1999 Cathepsin S required for normal MHC class II peptide loading and germinal center development Immunity 10 197 206 10072072 10.1016/S1074-7613(00) 80020-5 1:CAS:528:DyaK1MXhs1ymsro%3D (Pubitemid 29115625)
17. GK Sukhova Y Zhang JH Pan Y Wada T Yamamoto M Naito T Kodama S Tsimikas JL Witztum ML Lu Y Sakara MT Chin P Libby GP Shi 2003 Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice J Clin Invest 111 897 906 12639996 1:CAS:528:DC%2BD3sXitlOjtrk%3D (Pubitemid 37074965)
18. M Funicello M Novelli M Ragni T Vottari C Cocuzza J Soriano-Lopez C Chiellini F Boschi P Marzola P Masiello P Saftig F Santini R St Jacques S Desmarais N Morin J Mancini MD Percival A Pinchera M Maffei 2007 Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores PLoS ONE 2 e683 17668061 10.1371/journal.pone.0000683 (Pubitemid 351325416)
19. M Yang J Sun T Zhang J Liu J Zhang MA Shi F Darakhshan M Guerre-Millo K Clement BD Gelb G Dolgnov GP Shi 2008 Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice Arterioscler Thromb Vasc Biol 28 2202 2208 18818416 10.1161/ATVBAHA.108.172320 1:CAS:528:DC%2BD1cXhtlKrtrzM
20. SP Lutgens KB Cleutjens MJ Daemen S Heeneman 2007 Cathepsin cysteine proteases in cardiovascular disease Faseb J 21 3029 3041 17522380 10.1096/fj.06-7924com 1:CAS:528:DC%2BD2sXhtFKntbrE
21. Y Xiao H Junfeng L Tianhong W Lu C Shulin Z Yu L Xiaohua J Weixia Z Sheng G Yanyun L Guo L Min 2006 Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity J Clin Endocrinol Metab 91 4520 4527 16912123 10.1210/jc.2005-2486 (Pubitemid 44833434)
22. S Taleb R Cancello K Clement D Lacasa 2006 Cathepsin s promotes human preadipocyte differentiation: possible involvement of fibronectin degradation Endocrinology 147 4950 4959 16825321 10.1210/en.2006-0386 1:CAS:528: DC%2BD28XhtVSksbnM (Pubitemid 44402202)
23. J Antras F Hilliou G Redziniak J Pairault 1989 Decreased biosynthesis of actin and cellular fibronectin during adipose conversion of 3T3-F442A cells. Reorganization of the cytoarchitecture and extracellular matrix fibronectin Biol Cell 66 247 254 2690986 10.1016/0248-4900(89)90177-9 1:CAS:528:DyaK3cXltlOj (Pubitemid 19245710)
24. C Palermo JA Joyce 2008 Cysteine cathepsin proteases as pharmacological targets in cancer Trends Pharmacol Sci 29 22 28 18037508 10.1016/j.tips.2007.10. 011 1:CAS:528:DC%2BD1cXis1eiug%3D%3D
25. F Lecaille C Vandier E Godat V Herve-Grepinet D Bromme G Lalmanach 2007 Modulation of hypotensive effects of kinins by cathepsin K Arch Biochem Biophys 459 129 136 17181996 10.1016/j.abb.2006.10.033 1:CAS:528:DC%2BD2sXitFOktL4%3D (Pubitemid 46282593)
26. S Tada K Tsutsumi H Ishihara K Suzuki K Gohda N Teno 2008 Species differences between human and rat in the substrate specificity of cathepsin K J Biochem 144 499 506 18664521 10.1093/jb/mvn093 1:CAS:528:DC%2BD1MXis1WltA%3D%3D
27. S Desmarais F Masse MD Percival 2009 Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools Biol Chem 390 941 948 19453281 10.1515/BC.2009.092 1:CAS:528: DC%2BD1MXhtFWjs7jJ
28. Y Yasuda J Kaleta D Bromme 2005 The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics Adv Drug Deliv Rev 57 973 993 15876399 10.1016/j.addr.2004.12.013 1:CAS:528:DC%2BD2MXjvVKmsr8%3D (Pubitemid 40703885)
29. B Turk 2006 Targeting proteases: successes, failures and future prospects Nat Rev Drug Discov 5 785 799 16955069 10.1038/nrd2092 1:CAS:528: DC%2BD28XptVCltrs%3D (Pubitemid 44323703)